Bhopal News: AIIMS Told To Cut Patient Wait Times, Ensure Medicine Availability
AIIMS Governing Body and Institute Body (IB) have been asked to reduce patient waiting time. Meetings held on Thursday focused on improving patient services. Several important points were agreed upon, including reducing waiting time, ensuring uninterrupted availability of essential medicines, expanding various facilities and making hospital management more efficient through modern technology.

Bhopal News: AIIMS Told To Cut Patient Wait Times, Ensure Medicine Availability | AIIMS Bhopal
Bhopal (Madhya Pradesh): AIIMS Governing Body (GB) and Institute Body (IB) have been asked to reduce patient waiting time. Meetings held on Thursday focused on improving patient services.
Several important points were agreed upon, including reducing waiting time, ensuring uninterrupted availability of essential medicines, expanding various facilities and making hospital management more efficient through modern technology. Long-term strategy of the institute was also discussed. It was highlighted that AIIMS Bhopal has been consistently making significant efforts to enhance quality of patient services and streamline hospital management.
ALSO READ
Waiting times at AIIMS Bhopal remain long for certain procedures. MRI scans have a waiting period of three to four months, CT scans around two months. General patient consultations can take up to 3–4 days, and OPD appointments often require several weeks. While measures like the “AIIMS Swasthya” app and plans for a new centralised cancer block aim to reduce waits, delays persist, especially for diagnostics and specific treatments.
Due to long waits, many patients seek expensive alternatives at private centres. Patients, particularly those from distant areas, face significant challenges in obtaining timely treatment.
Members of Parliament including Bhopal MP Alok Sharma, Bharat Singh Kushwah, Rajya Sabha MP Vivek Tankha and others were present. The meeting was chaired by Prof. (Dr.) Ashok Kumar Mahapatra (President) and Prof. (Dr.) Madhabananda Kar (Executive Director & CEO).
RECENT STORIES
-
Brent Crude Likely To Hit $90 Per Barrel In December 2026 Amid West Asia Supply Risks: Goldman Sachs -
Small-Cap Mutual Fund Inflows Jump 13.4% To ₹9,039 Crore In Sep Despite Market Weakness -
Navi Mumbai Matrimonial Fraud: Home Guard, Accomplice Arrested For Allegedly Cheating 2 Women Of... -
Essix Biosciences Acquires 14 lakh Equity Shares Of Ind-Swift Laboratories -
How Were Rahul, Priyanka Elected To Parliament If ECI Is At Fault, Asks MP Minister Vishwas Sarang...
